28,450.00
+250(+0.89%)
Currency In KRW
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
309
First IPO Date
January 04, 2000
| Name | Title | Pay | Year Born |
| Mr. Su-Jin Park | Co-Chief Executive Officer, Vice President & Director | 0 | 1972 |
| Mr. Sean Jeong | President, Co-Chief Executive Officer & Director | 0 | 1971 |
| Mr. Christopher W. Slavinsky | Chief Business Development & Legal Officer | 0 | 1973 |
| Nam-Yong Cho | Senior Executive Director of Sales & Marketing and Senior Managing Director | 0 | 1954 |
| Mr. Jae-Seung Yoon | C.V.O | 0 | 1962 |
Hanall Biopharma Co.,Ltd, a pharmaceutical company, researches, develops, and sells pharmaceutical products in South Korea and internationally. The company offers specialty drugs and over-the-counter products for the treatment of gastric and duodenal ulcers, gastritis, cerebrovascular and peripheral blood vessel disorder, hypertension, atherosclerotic symptom, acute coronary syndrome, atherothrombosis and thromboembolism, diabetes, osteoporosis, chronic kidney failure, hypothyroidism, vitamin D-resistant rickets, osteomalacia, erectile dysfunction, prostatic hyperplasia, candidiasis, various fungal infections, prostate cancer, formal, constipation, thin stools, bloating, bowel abnormal fermentation, and hemorrhoids. The company was founded in 1973 and is based in Seoul, South Korea.